IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex formation of both major peanut allergens
Journal of Allergy and Clinical Immunology · 2023-08 · 152 (2) · 436-444.e6
DOI: 10.1016/j.jaci.2023.03.025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2023-08. Verfasst von Hans J M Warmenhoven und 5 weiteren Autor:innen. Beteiligte Einrichtung: HAL Allergy, J. H. Oortweg, Leiden, The Netherlands; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam, The Neth…. Hauptthemen laut MEDLINE: Allergens, Peanut Hypersensitivity. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, UvA-Amsterdam UMC, Amsterdam University Medical Centers.
Abstract (Originalsprache)
BACKGROUND: Surprisingly, IgE cross-reactivity between the major peanut allergens Ara h 1, 2, and 3 has been reported despite very low sequence identities. OBJECTIVE: We investigated the unexpected cross-reactivity between peanut major allergens. METHODS: Cross-contamination of purified natural Ara h 1, 2, 3, and 6 was assessed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE), Western blot test, liquid chromatography-tandem mass spectrometry (LC-MS/MS), and sandwich enzyme-linked immunosorbent assay (ELISA). IgE cross-reactivity was studied with sera of peanut-allergic patients (n = 43) by ELISA and ImmunoCAP inhibition using both intact natural and recombinant allergens and synthetic peptides representing postulated Ara h 1 and Ara h 2 cross-reactive epitopes. RESULTS: Both purified nAra h 1 and nAra h 3 were demonstrated to contain small but significant amounts of Ara h 2 and Ara h 6 (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- HAL Allergy, J. H. Oortweg, Leiden, The Netherlands; Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- HAL Allergy, J. H. Oortweg, Leiden, The Netherlands.
- Department of Medicine, Division of Allergy and Clinical Immunology, University of Colorado-Denver, Aurora, Colo.
- Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
- Department of Experimental Immunology, Amsterdam University Medical Centers, Amsterdam, The Netherlands; Department of Otorhinolaryngology, Amsterdam University Medical Centers, Amsterdam, The Netherlands. Electronic ad…
Förderung
- NIAID NIH HHS
- UvA-Amsterdam UMC
- Amsterdam University Medical Centers
Zitieren
APA
Warmenhoven, H. J. M., Hulsbos, L., Dreskin, S. C., Akkerdaas, J. H., Versteeg, S. A., & van Ree, R. (2023). IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex formation of both major peanut allergens. Journal of Allergy and Clinical Immunology, 152(2), 436-444.e6. https://doi.org/10.1016/j.jaci.2023.03.025
Vancouver
Warmenhoven HJM, Hulsbos L, Dreskin SC, Akkerdaas JH, Versteeg SA, van Ree R. IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex formation of both major peanut allergens. Journal of Allergy and Clinical Immunology. 2023;152(2):436-444.e6. doi:10.1016/j.jaci.2023.03.025
BibTeX
@article{Warmenhoven2023,
author = {Warmenhoven, Hans J M and Hulsbos, Luuk and Dreskin, Stephen C and Akkerdaas, Jaap H and Versteeg, Serge A and van Ree, Ronald},
title = {IgE cross-inhibition between Ara h 1 and Ara h 2 is explained by complex formation of both major peanut allergens},
journal = {Journal of Allergy and Clinical Immunology},
year = {2023},
volume = {152},
number = {2},
pages = {436--444.e6},
doi = {10.1016/j.jaci.2023.03.025}
}
EUVIMED